News from MarketWatch Top Stories

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Ceo Tariffs Stocks Investors Crypto Assets Shares Stock Cryptocurrency Stock Market Ethereum Price Markets Xrp Investment Blockchain Stablecoin Etf Sec Eth Bse Ipo Trade Index Solana Earnings Revenue China Coinbase Inflation Token Wall Street Nasdaq Interest Rates Sensex Gold Usd Traders Treasury Trade War Nse Economy Federal Reserve Tesla Profit Bse Sensex Digital Assets Sp 500 Fed Rate Cuts Trans Mountain Pipeline Victorian Treasurer Sportfi Strive Operational Efficiencies Consumer Loyalty Technology Funds Equitas Small Finance Bank Uk Competitiveness

Filter by:

Eli Lilly × MarketWatch Top Stories ×

MarketWatch Top Stories • May 12, 2025

Here’s how much extra weight is lost with Zepbound over Wegovy

A recent comparison of two popular weight-loss medications highlighted a measurable difference in effectiveness, potentially influencing market share and revenue for the companies...

Read Full Article →